Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...
Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback